Equities By Region UK

Barclays share price outperforms as Berenberg turns bullish on bank

Share this article!

Shares in Barclays (LON:BARC) have climbed higher in today’s session, outperforming the broader UK market, as Berenberg lifted its rating on the blue-chip lender. Proactive Investors quoted the analysts as arguing that the group has the “strongest franchise of any non-US bank in the profitable US investment bank market”.

As of 13:41 BST, Barclays’ share price had added 0.92 percent to 173.36p, outperforming the broader UK market, with the benchmark FTSE 100 index having slipped marginally into the red and currently standing 0.15 percent lower at 7,499.26 points. The group’s shares have lost more than 10 percent of their value over the past year, as compared with a near two-percent gain in the Footsie.

Berenberg Bank says ‘buy’

Berenberg hiked its rating on Barclays from ‘hold’ to ‘buy’ today, lifting its price target on the shares from 200p. to 220p, flagging improved returns from the group’s investment banking arm.

“Despite our cautious investment bank revenue outlook, and past concerns around strategy, the market’s expectation of a 5.5-percent return on tangible equity (RoTE) from Barclays’ investment bank is too low,” the broker pointed out, as quoted by Proactive Investors, adding that the group had “the strongest franchise of any non-US bank in the profitable US investment bank market and is gaining market share”.

The analysts believe that Barclays’ investment bank returns could “rise towards nine percent by fiscal year 2020 with group returns bolstered further by its best-in-class UK business”.

Other analysts on Barclays

Credit Suisse, which also rates the FTSE 100 lender as a ‘buy,’ hiked its price target on the shares from 235p to 240p last week. According to MarketBeat, Barclays currently has a consensus ‘buy’ rating and an average price target of 228.11p.

As of 13:59 BST, Monday, 01 October, Barclays share price is 173.40p.

Add Comment

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.